Oxford and Serum Institute Launch R78C Next-Generation Malaria Vaccine to Transform Treatment Across Africa

About this episode

The episode discusses the launch of the R78C malaria vaccine by the University of Oxford and Serum Institute of India, highlighting its potential impact on malaria treatment in Africa.

The University of Oxford and Serum Institute of India have announced a landmark partnership to develop R78C, a next-generation malaria vaccine targeting multiple stages of the Plasmodium falciparum parasite's lifecycle, according to NDTV reports. This licensing agreement aims to accelerate clinical trials, large-scale manufacturing, and potential rollout, with experts noting its potential for stronger immune responses, longer protection, and reduced transmission compared to earlier vaccines like RTS,S and R21. R78C focuses on blood-stage antigens RIPR and CyRPA, addressing the phase when symptoms peak and severity rises, unlike prior shots that primarily hit the sporozoite entry stage. NDTV highlights that Serum Institute's manufacturing prowess could make the vaccine affordable for widespread use in high-burden areas. While still in early development, the collaboration signals a shift toward multi-stage strategies to overcome limitations of existing vaccines, both WHO-prequalified. In Cameroon, ongoing malaria vaccine rollouts are yielding positive results, as shared in an Africanews report. Mothers report significant health improvements in children after receiving doses, with…

Topics covered

• malaria vaccine
• healthcare innovation
• clinical trials
• public health
• vaccine development

Keywords

• malaria
• vaccine
• R78C
• clinical trials
• public health
• Serum Institute
• Oxford
• Plasmodium falciparum
• immunization

Mentioned in this episode

Organizations: University of Oxford, Serum Institute of India, NDTV, WHO, Malariaworld

Products: R78C, RTS,S, R21

Places: Cameroon

More episodes of Malaria Vaccine

• **Next-Generation Malaria Vaccine R78C Offers Hope as Global Cases Rise to 282 Million** · May 5, 2026 · 4 min
• Malaria Vaccine Updates: Where to Find the Latest News and Official Health Resources · May 1, 2026 · 1 min
• Malaria Vaccines Transform Africa: 32% Case Drop in Burkina Faso Despite Funding and Misinformation Challenges · April 28, 2026 · 2 min
• R21 Malaria Vaccine Dramatically Cuts Cases and Deaths Across Africa, But Funding Gaps and Misinformation Threaten Progress · April 26, 2026 · 2 min
• Malaria Vaccine Rollout Stalled by Funding Cuts and Misinformation Despite Scientific Breakthroughs · April 24, 2026 · 4 min
• Breakthrough Malaria Vaccines and New Treatments Offer Hope for Elimination by 2026 · April 21, 2026 · 2 min